Satellos Bioscience Inc Com V.ICO

Primary Symbol: ICOTF

Healthcare Biotechnology

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...

GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > Results

<< Previous

Bullboard Posts

Next >>

Comment by MountainMasteron Jun 27, 2018 3:49pm

260 Views

Post# 28239597

RE:Results

The pharmacokinrtic results that were spoken about today at the meeting are due shortly. These results and the funding coming will put ICO in the .40-.50 range at the min.

MountainMaster wrote: The pharmacokinetic results will be in sooner than expected and preliminary testing shows nothing other than positive data. These are the results that are going to send ICO to new super HIGHS. As seen today the news was earlier than expected. Management says we could see the phamacokinetic data as early as next week. There will be no financing because funds are coming in from grants, partnerships, licensing and foundations. This is the beggining of a super company thats about to blow up, years in the making and happening now.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?